BMS posts double-digit income rise despite heathcare reform hit
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb's EPS was hit by three cents as a result of US healthcare reform in the first quarter, which led the company to lower its full-year GAAP EPS guidance by 10 cents.